At a Glance

• Dr. Dan Drucker is a clinician-scientist who develops treatments for diabetes, obesity, and intestinal disorders
• He studies a family of hormones produced in the pancreas, gastrointestinal tract and brain
• In 2008,  Dr. Drucker reported that a new once-weekly treatment for type 2 diabetes could replace the more common twice-daily injection
• His lab has discovered two new treatments for type 2 diabetes – and is working on a treatment for Crohn’s disease
• He holds the Canada Research Chair in Regulatory Peptides; received the Prix Galien Canada Research Award 2008 for his substantial contribution to the diagnosis, prevention or treatment of diseases; and the 2009 Clinical Investigator Award from The Endocrine Society
• Recipient of the 2011 Claude Bernard Lecture/Award of the European Association for the Study of Diabetes

Major Research Activities

A pioneer in diabetes treatment, Dr. Drucker’s work has provided important insights leading to the development of new drugs for the treatment of Type 2 diabetes. Currently, his laboratory at the Lunenfeld focuses on understanding the biology of glucagon-like peptides.

Recent Publications

http://www.glucagon.com/druckerpublications.html

► Lunenfeld Research Repository